Blood, stress, and tiRNAs by Williams, Ruth
T
H
E
J
O
U
R
N
A
L
O
F
C
E
L
L
B
I
O
L
O
G
Y
3
In Focus
Text by Ruth Williams
ruth.williams@rockefeller.edu
IN FOCUS • THE JOURNAL OF CELL BIOLOGY
Blood, stress, and tiRNAs
M
any of us experience destructive 
urges when stressed. Cells actu-
ally act on them, by chopping 
tRNA molecules to pieces. Two studies, one 
in yeast and one in human cells, identify the 
tRNA molecular scissors. 
Stressed cells reduce their levels of 
protein production to conserve energy and 
resources (1). One way they do this is to 
switch off a protein production factor called 
eIF2. In cells that contain a permanently 
‘on’ version of eIF2, however, protein 
production can still be dialed down by 
stress. Yamasaki et al. thought that stress-
induced tRNA destruction, as reported in 
bacteria, fungi, and mammals, might be 
a backup mechanism for stalling protein 
synthesis (destroy the tRNAs, destroy the 
amino acid source).
The Harvard-based team identifi  ed a 
somewhat unexpected stress-induced tRNA-
hacking factor in human cells (2). They 
found that angiogenin—a secreted protein 
better known for its blood vessel building 
properties—directly cleaved tRNAs, and 
that the resulting fragments (tiRNAs) halted 
protein synthesis. These tiRNAs only sup-
pressed synthesis if they contained a certain 
part of the original tRNA molecules (the 
5 end). Exactly why is unclear, but the 
authors suggest that the 5 end fragments 
possess a modifi  cation that makes them 
resistant to degradation.
What’s also unclear is how angiogenin’s 
blood vessel building activity is linked to its 
part in the stress response. Senior author Paul 
Anderson speculates that although tiRNAs 
reduce general levels of protein synthesis, 
some proteins might be preferentially pro-
duced during stress. “[Angiogenin] might 
actually turn on the translation of certain 
other angiogenic factors.”
It is plausible that mammalian tissues 
might need new blood vessels after heat 
shock or UV irradiation (two of the stress 
conditions used). And, as Anderson points 
out, angiogenin requires its RNA cleavage 
function to promote blood vessel growth, so 
“using Occam’s razor, it’s likely that there’s 
a link between the two.”
Yeast don’t have a blood supply, of 
course, but they do chop up tRNAs when 
stressed. In a second study, Thompson and 
Parker identify the enzyme responsible as 
Rny1p. This enzyme, they show, is released 
from the yeast cell vacuole into the cyto-
plasm during stress (3).
Thompson and Parker speculate that 
Rny1p-produced tRNA fragments reduce pro-
tein production just like their human cell equiv-
alents, though this was not the subject of their 
investigation. Instead the two researchers from 
Arizona uncovered a secondary stress-induced 
function of Rny1p—promoting cell death.
Overexpression in yeast of Rny1p or its 
human orthologue RNASET2 led to reduced 
viability. Following this hint, 
the authors went on to con-
fi  rm Rny1p’s death-promot-
ing ability by showing that 
suicide-prone yeast could be 
rescued by deleting Rny1p.
Surprisingly, Rny1p’s 
death-promoting function 
is independent of its tRNA 
cleavage activity. Release 
of Rny1p from the vacuole 
might be analogous to the release of cyto-
chrome c from mitochondria, which trig-
gers apoptosis, surmise the authors. The 
increasing cytoplasmic Rny1p would be a 
stress signal to the cell. A small increase, 
and tRNA destruction might be suffi  cient 
stress relief. A big increase, and suicide 
might be the only answer.
Working out how the cell senses 
Rny1p, and decides upon its fate is the 
subject of Thompson and Parker’s next 
experiments. Determining whether RNA-
SET2 plays a similar role in mammalian 
cells will be of interest too, especially 
since RNASET2 has a cleavage-indepen-
dent tumor-suppressing activity. Mam-
malian cells don’t have vacuoles, but they 
do have lysosomes, where RNASET2 can 
be found. And certain drugs that increase 
lysosome membrane permeability induce 
apoptosis (4).
Interestingly, even though RNA-
SET2 is capable of cleaving tRNAs, and 
can functionally replace Rny1p in yeast 
cells, it does not appear 
to be involved in tiRNA 
production in humans—
the role instead going 
to angiogenin. “In yeast 
there’s one nuclease and 
it does both these things,” 
says Parker. “But maybe in 
mammalian cells it’s more 
complicated… it’s always 
more complicated.”
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(L-R) Debrah Thompson and Roy Parker ﬁ  nd that a ribonuclease called Rny1p is mainly localized to 
the vacuole in yeast cells (left), but stress (right) sends it to the cytoplasm, where it chops up tRNAs 
and can promote cell suicide. In human cells angiogenin does the tRNA chopping, show Satoshi 
Yamasaki and Pavel Ivanov, lead authors on Anderson’s study.
“But maybe in 
mammalian 
cells it’s more 
complicated… 
it’s always more 
complicated.”
Two studies identify the pathways to tRNA destruction under stress.
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